• Investor Relations
PRESS

31.05.2023

Medios AG: Supervisory Board extends contract with Chief Financial...

Acquisition

Medios acquires NewCo Pharma Group

Medios expands its market position in compounding and taps new growth potentials

More
Sustainability

Think about tomorrow

Sustainability strategy published – comprehensive Sustainability program to be implemented by 2025

More
Reporting Center

All Information regarding Corporate Development

Annual Report 2022

More
Annual General Meeting

Annual General Meeting of Medios AG

The Annual General Meeting 2022 of Medios AG was take place on June 21, 2022 as a virtual Annual General Meeting. You can find essential information here.

More
Corporate Calender

Dates and Events

More
Corporate Governance

For Maximum Transparency

More

Growth Market

Specialty Pharma Medicinal Products

Focus on Patients

Pioneer on the Stock Exchange

Medios AG is one of the best-known companies in the growth market of specialty pharmaceuticals in Germany.

Specialty pharma medicinal products are medicines for patients with rare or chronic diseases such as cancer, HIV, hepatitis or hemophilia.

Our work centers on patient wellbeing.

Medios AG is Germany's first specialty pharmaceutical company to be listed on the stock exchange.

Contact

Claudia Nickolaus
Head of Investor & Public Relations
ESG Communications

 +49 30 232 566 800

 ir@medios.ag

 

Stay informed Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date. 

Registration is free of charge and can be revoked at any time.

Click here to register